Friday, August 18, 2017 6:26:49 AM
Was seeking some insight for your hunch on Toyota/Palmetto alignment AND, drum roll please, Palmetto primarily licensing our tech for auto trunk liner material at this time. Whether this is going to Lexington Kentucky, ahh, nuther matter.
Neutraceuticals closer than pharma. With Brockway on our board, cosmetics are viewed as a low hanging fruit. Pre-commercial tagging for mil-spec items also maturing into long term contracts as evidenced by our sign up of the bearing manufacturer.
On our tooling and maintenance agreements, we DO design and control the manufacturing of the mechanisms, applicators and field units deployed in our systems. Service contracts include higher level assay testing which can be done now within a ½ hour. Mean time between failure (MTBF) is a universal factor used across all industrial systems, BUT, we don't publish spec sheets or have product catalogs with leggy, buxomous blonds draped over fiftyfive gallon drums of joy juice.
Each system is wholly unique, have to interface with the system in place, wholly designed in house and contracted out to local machine shops. Long Island does have those. Maintenance and assay services follow closely to the free razor now buy the blade models. Acrobat Reader from Adobe another example
On feasibilities, the $3.5 million to break even bar cited by Hayward IS our standard going forward. We will take on challenges as they come but not likely to branch out past marking and assaying and maintenance as the costs and returns on new ventures aren't seen as worth the squeeze.
They haven't been able to establish an average pilot project time as each is wholly unique in tailoring to the current manufacturing system and expectations of each customer. Got some more but have to haul my asset off to work.
Go through my "copious" notes. Got a date night tonight.
GLTA
Recommend more dialog with Sanjay, cotton, PET, Leather and fertilizer, cosmetics, industrial lubricants, gotta go
Recent APDN News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/04/2024 10:18:33 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 09:25:36 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/12/2024 09:09:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:05:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/08/2024 09:01:31 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/01/2024 09:05:28 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:24:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/10/2024 10:16:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:05:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/07/2023 09:01:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:05:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 10:09:34 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/07/2023 10:02:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:05:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:01:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 08:02:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 09:04:44 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM